Zobrazeno 1 - 9
of 9
pro vyhledávání: '"R. Stephens Crockett"'
Autor:
Thomas K. Mundorf, Noritsugu Inui, R. Stephens Crockett, Gary D. Novack, Takahiro Ogawa, Hiroaki Naka
Publikováno v:
Current Medical Research and Opinion. 21:369-373
A new formulation of timolol with sorbic acid, timolol-LA (TLA) (Istaloldagger), has been developed which increases its ocular bioavailability. In the present study, we desired to evaluate the ocular comfort and systemic bioavailability of TLA in hea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7792b346af12afdf1a81626937e8c91f
https://doi.org/10.1185/030079905x36378
https://doi.org/10.1185/030079905x36378
Publikováno v:
Ophthalmology. 112:84-91
To evaluate the safety and efficacy of the relatively selective M(1)-antagonist, pirenzepine ophthalmic gel (gel), in slowing the progression of myopia in school-aged children.Parallel-group, placebo-controlled, randomized, double-masked study.Three
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40e329b8e1f87c0801d1015bd4a40369
https://doi.org/10.1016/j.ophtha.2004.06.038
https://doi.org/10.1016/j.ophtha.2004.06.038
Publikováno v:
Clinical Therapeutics. 26:541-551
Background: Timolol maleate, a nonselective β-adrenoceptor antagonist applied topically to the eye as a solution, is well known for its ocular hypotensive efficacy. A gellan formulation of timolol maleate is given once daily and has been shown to be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56d88e255cb5e3675c51506968e2a0c3
https://doi.org/10.1016/s0149-2918(04)90056-2
https://doi.org/10.1016/s0149-2918(04)90056-2
Autor:
R. Stephens Crockett, Gary D. Novack
Publikováno v:
The Ocular Surface. 7:163-165
©2009 Ethis Communications, Inc. The Ocular Surface ISSN: 1542-0124. Novack GD, Crockett RS. Regression to the mean. 2009;7(3):163-165. W e are frequently involved in evaluating studies of new ophthalmology agents. The efficacy of some treatments ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf0be487a0cff883b2b0f22edf85b7ba
https://doi.org/10.1016/s1542-0124(12)70311-7
https://doi.org/10.1016/s1542-0124(12)70311-7
Publikováno v:
American journal of ophthalmology. 149(4)
Purpose To evaluate the efficacy and safety of 0.18% sodium hyaluronate ophthalmic solution (Rejena, Vismed) compared with its vehicle for the treatment of signs and symptoms of dry eye disease. Design Randomized, placebo-controlled clinical trial. M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e62b0fed4a965a525d5fa41e38911bef
https://pubmed.ncbi.nlm.nih.gov/21036218
https://pubmed.ncbi.nlm.nih.gov/21036218
Publikováno v:
American journal of ophthalmology. 144(4)
● PURPOSE: To determine with electronic monitoring an objective measurement of adherence in two populations of subjects: those using once-daily prostaglandin analogs as sole ocular hypotensive therapy (one-drug group) and those requiring an adjunct
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d4fee4d4605a5ee4586d6bb77cc2d3a
https://pubmed.ncbi.nlm.nih.gov/17686450
https://pubmed.ncbi.nlm.nih.gov/17686450
Publikováno v:
Clinical therapeutics. 26(4)
Timolol maleate, a nonselective beta-adrenoceptor antagonist applied topically to the eye as a solution, is well known for its ocular hypotensive efficacy. A gellan formulation of timolol maleate is given once daily and has been shown to be as effect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1030cee18b7c283bb3d4030d27f0d6bf
https://pubmed.ncbi.nlm.nih.gov/15189751
https://pubmed.ncbi.nlm.nih.gov/15189751
Autor:
Susan A. Cotter, Colin Scher, Joseph M. Miller, R. Michael Siatkowski, Gary D. Novack, R. Stephens Crockett
Publikováno v:
Archives of Ophthalmology. 122:1667
To evaluate the safety and efficacy of the relatively selective M(1) antagonist pirenzepine hydrochloride in slowing the progression of myopia in school-aged children.This was a parallel-group, placebo-controlled, double-masked study in healthy child
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::928741156ab419613d6bd7bdefbe9221
https://doi.org/10.1001/archopht.122.11.1667
https://doi.org/10.1001/archopht.122.11.1667
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.